Steris this week announced that its jury trial against its subsidiary Isomedix Operations ended in a mistrial.
Steris said the trial against its Isomedix subsidiary was dismissed and will be rescheduled for a later date. The Irish medical-device company said the case, which began on Dec. 4, was declared a ...
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results